Biotech & MedTech
-
David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies
In this InvestorIntel interview, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David Regan provides Tracy Weslosky with…
-
Thomas Smeenk provides an update on Hemostemix’s ACP-01 stem cell treatment for heart disease
Peter Clausi interviews Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, President and CEO Thomas Smeenk about an…
-
Greg Fenton on the ZenGUARD™ technology patent and how HVAC filter testing results mean better air for everyone
In this InvestorIntel interview, Tracy Weslosky has Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg…
-
Zentek in the Global Spotlight for ZenGUARD™ Technology Patent
Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN), an IP development and commercialization company, has recently achieved a major…
-
Steve Saviuk on how Valeo Pharma’s ‘life changing’ products have delivered the strong growth forecasted for 2022
In this InvestorIntel interview, Tracy Weslosky interviews Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO and…
-
Valeo Pharma keeps delivering with a 100% revenue growth forecast in 2022 and more new effective pharmaceuticals
Early in 2022 InvestorIntel updated readers about a company that was growing its revenue at an incredible rate…
-
Cardiol Therapeutics is concerned with affairs of the heart
One thing I really enjoy about writing for InvestorIntel is all the random learning I get from reading…